IC COMPANYS A/S QUARTERLY REPORT CONSOLIDATED REVENUE FOR Q1 2013/14 AMOUNTED TO DKK 1,052 MILLION WHICH IS AT THE SAME LEVEL AS Q1 2012/13. THE UNCHANGED REVENUE DEVELOPMENT COMPARED TO Q1 2012/13 COMPRISES TWO OPPOSING, YET EXPECTED, TRENDS; GROWTH IN THE PREMIUM SEGMENTS AND REVENUE SETBACK IN THE MID MARKET SEGMENT. THE GROUP’S GROSS MARGIN AMOUNTED TO 56.0% FOR THE QUARTER UNDER REVIEW COMPARED TO 57.3% IN Q1 2012/13. THE OPERATING PROFIT FOR Q1 2013/14 AMOUNTED TO DKK 159 MILLION. * Revenue from the Premium Outdoor segment, which comprises the brand Peak Performance, rose by 2% to DKK 344 million (DKK 336 million) which is attributable to satisfactory growth in sales to wholesale customers, yet affected by a disappointing performance in the retail channel. The Premium Outdoor operating profit amounted to DKK 69 million (DKK 76 million). This setback in the segment’s operating profit is primarily driven by higher costs for development of e-commerce and retail distribution. * Revenue from the Premium Contemporary segment, which comprises the brands Tiger of Sweden and By Malene Birger, rose by 8% to DKK 342 million (DKK 316 million). This achieved growth was particularly attributable to insourcing of Tiger of Sweden’s accessory line as well as the segment’s wholesale channel. The Premium Contemporary operating profit for Q1 2013/14 amounted to DKK 54 million (DKK 56 million) and was affected by higher costs in connection with e.g. insourcing of Tiger of Sweden’s accessory line, higher marketing costs as well as continued development of the segment’s retail channel. * Revenue from the Mid Market Contemporary segment suffered a setback of 13% to DKK 234 million (DKK 270 million) which was as expected. The Mid Market Contemporary operating profit rose to DKK 21 million (DKK 14 million) primarily as a consequence of the implemented restructurings and cost saving measures. * The Group’s gross margin declined by 1.3 percentage points compared to Q1 2012/13. This decline is partly attributable to a higher exchange rate of the Group’s primary sourcing currency (USD) compared to last financial year. In addition to this, the gross margin for Q1 2012/13 was positively affected by a large-scale clearing of products out-of-season. * The capacity costs were reduced by DKK 6 million to DKK 430 million corresponding to a cost rate of 41%. * Operating profit amounted to DKK 159 million (DKK 165 million) corresponding to an EBIT margin of 15.1% (15.7%). After having adjusted for costs incurred in Q1 2013/14 in connection with changes to the Executive Board, the operating profit amounted to DKK 169 million corresponding to an EBIT margin of 16.1%. UNCHANGED OUTLOOK FOR CONTINUING OPERATIONS FOR 2013/14 The Group’s Premium brands are expected to continue the positive development and generate solid growth rates for 2013/14. As a consequence of the challenges in the Group’s Mid Market segment, which is expected to suffer a revenue setback, the total consolidated revenue growth for 2013/14 is expected to be modest. However, earnings are expected to be improved in all segments and the total consolidated earnings are consequently expected to increase significantly compared to DKK 157 million realised in 2012/13. Investments for the financial year 2013/14 are expected to attain a level of DKK 70-90 million primarily for an expansion of the distribution in the two Premium segments. At the Annual General Meeting 2013 a resolution was adopted recommending DKK 2.00 per ordinary share, corresponding to a total dividend of DKK 33 million, in respect of the financial year 2012/13 to be distributed as dividend to the shareholders. Furthermore, during the financial year 2013/14 Management expects to distribute DKK 100 million through a combination of share buy-back and extraordinary dividend. Copenhagen, 13th November 2013 IC COMPANYS A/S Mads Ryder, Group CEO Tine Knarreborg, Acting Chief Financial Officer
Revenue growth in the Premium segments. Improved earnings
Top 10 Most Recent News Articles
Hyliion Class Action Deadline Nears for Investors
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue ReadingTop 5 Most Recently Viewed Articles
Key Economic Indicators Shaping Financial Markets This Week
Key Economic Indicators Impacting Financial Markets This Week As traders prepare for another important trading day, there’s a significant emphasis on crucial decisions and economic data releases that are expected to sway market trends. Particularly, the Manufacturing and Services PMI reports are critical indicators of current economic conditions and business sentiment....
Continue Reading
Innovative Alliance Launched for Sustainable Aviation Fuel Production
Innovative Alliance for Sustainable Aviation Fuel In a forward-thinking move, industry leaders Honeywell (NASDAQ: HON), Johnson Matthey, GIDARA Energy, and SAMSUNG E&A have united to form a strategic technology alliance aimed at revolutionizing the production of Sustainable Aviation Fuel (SAF). This collaboration focuses on converting biomass and municipal solid waste...
Continue Reading
Pfizer's Strategy to Strengthen Bid for Metsera Amid Rivalry
Pfizer's Bold Move in the Metsera Acquisition Battle The Delaware Chancery Court recently ruled against Pfizer Inc. (NYSE: PFE), rejecting its request for a temporary restraining order aimed at blocking Metsera, Inc. (NASDAQ: MTSR) from terminating its merger agreement with Pfizer in light of a competing proposal from Novo Nordisk A/S (NYSE: NVO). Pfizer's Response to the...
Continue Reading
Innovative Garden Movement Highlighted in Film Premiere
Film Premiere Celebrates Gardening Activism Miranda Winters and Rocky Romano are excited to announce a significant event that stands out in the film industry—a premiere of their thought-provoking short film, "Gangsta Gardener." This highly anticipated event will take place at the prestigious Hammer Museum, an influential cultural institution representing creativity and...
Continue Reading
SineuGene Advances Gene Therapy for ALS into Global Trials
Exciting Developments in Gene Therapy for ALS SineuGene Therapeutics Co., Ltd., a pioneering clinical-stage biotechnology company, recently achieved a significant milestone in the development of innovative treatments for amyotrophic lateral sclerosis (ALS). The company has secured clearance for its Investigational New Drug (IND) application for SNUG01, a novel gene...
Continue Reading